Drugs Considered Breakthrough Therapies

In 2014 the FDA designated nine novel drugs as Breakthrough therapies, in which preliminary clinical evidence demonstrates that the drug may result in substantial improvement on at least one clinically significant endpoint over other available therapies.

Related Topics